| 注册
首页|期刊导航|中国现代中药|药食同源领域政策法规发展历程回顾与展望

药食同源领域政策法规发展历程回顾与展望

范乐洋 许利嘉 刘海波 董政起

中国现代中药2026,Vol.28Issue(5):869-875,7.
中国现代中药2026,Vol.28Issue(5):869-875,7.DOI:10.13313/j.issn.1673-4890.20250820008

药食同源领域政策法规发展历程回顾与展望

Review and Prospect of the Policies in Field of Medicine and Food Homology

范乐洋 1许利嘉 1刘海波 1董政起1

作者信息

  • 1. 中国医学科学院 北京协和医学院 药用植物研究所,北京 100193
  • 折叠

摘要

Abstract

The concept of"medicine and food homology"originated from ancient medical practices and has been continuously enriched and developed throughout history,gaining widespread public recognition.In 1987,the Measures for Hygienic Administration of Prohibiting the Addition of Drugs to Food delineated the boundary between food and drugs.As an interdisciplinary area bridging food and pharmaceuticals,the regulatory complexity of medicine and food homology has gradually become increasingly prominent.Since then,China's policy supervision of medicine and food homology has undergone four stages,including initiation,standardization,development,and refinement,gradually establishing a comprehensive and scientific regulatory system.This paper systematically compiles policies and regulations in the field of medicine and food homology,traces the evolutionary trajectory of the policy system,and looks ahead to future trends,providing a reference for the study and understanding of China's distinctive regulatory system.

关键词

药食同源/食药物质/政策法规

Key words

medicine and food homology/edible medicinal substances/policies and regulations

分类

医药卫生

引用本文复制引用

范乐洋,许利嘉,刘海波,董政起..药食同源领域政策法规发展历程回顾与展望[J].中国现代中药,2026,28(5):869-875,7.

基金项目

中国医学科学院医学与健康科技创新工程项目(2022-I2M-1-018) (2022-I2M-1-018)

中国现代中药

1673-4890

访问量0
|
下载量0
段落导航相关论文